Clinical Trials
10 trialsNCT05464810 2025-05-23
Letrozole With and Without Simvastatin for the Treatment of Stage I-III Hormone Receptor Positive, HER2 Negative Breast Cancer
Emory University
Phase EARLY_PHASE1 Recruiting
NCT03324425 2025-02-27
SIMPHONY
Baylor Breast Care Center
Phase 2 Active not recruiting
NCT05550415 2024-10-03
The Role of Simvastatin in the Epithelial-Mesenchymal Transition Process of Breast Cancer
Indonesia University
Phase 2 Recruiting
NCT02096588 2024-07-09
Detection and Prevention of Anthracycline-Related Cardiac Toxicity With Concurrent Simvastatin
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Terminated
NCT03454529 2023-08-01
The Effect of Simvastatin on Breast Cancer Cell Growth in Women With Stage I-II Breast Cancer
Barbara Ann Karmanos Cancer Institute
Phase 2 Completed
NCT04418089 2020-06-05
Simvastatin Effect in Combination With Neoadjuvant Chemotherapy to Clinical Response and Tumor-Free Margin in Locally Advanced Breast Cancer
Indonesia University
Phase 2 Completed
NCT00334542 2019-04-03
Simvastatin in Preventing a New Breast Cancer in Women at High Risk for a New Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT01500577 2014-06-18
A Prevention Trial in Subjects at High Risk for Breast Cancer
European Institute of Oncology
Phase 2 Completed
NCT00807950 2014-01-22
Phase II Study of Simvastatin in Primary Breast Cancer; Test of Its Potential Selectivity on Basal Subtype Breast Cancer
National University Hospital, Singapore
Phase 2 Unknown
NCT00354640 2013-06-24
Simvastatin and Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ or Invasive Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed